Access
To read this story in full you will need to login or make a payment (see right).
Correspondence
Nature 458, 1101 (30 April 2009) | doi:10.1038/4581101a; Published online 29 April 2009
Open Innovation Challenges
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
- More Challenges
- Powered by:
nature jobs
Assistant or Associate Professor - Cell & Systems Biology
- University of Toronto
- Toronto, ON Canada
Basic Science Medical Educators
- Texas Tech University Health Sciences Center
- El Paso, Texas, USA
Stem-cell treatments for spinal-cord injury may be worth the risk
Jesse Owens1
- Biomedical Program, University of Alaska, Anchorage, Alaska 99508, USA
Email: afjlo@uaa.alaska.edu
In his Correspondence 'Caution urged in trial of stem cells to treat spinal-cord injury' (Nature 458, 29; 2009), Yves Barde questions the wisdom of testing oligodendrocyte precursors derived from embryonic stem (ES) cells in patients, despite the promise that such cells hold for repairing these injuries in rodents.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Hypointense Transcerebral Veins at T2*-Weighted MRI: A Marker of Hemorrhagic Transformation Risk in Patients Treated With Intravenous Tissue Plasminogen ActivatorJournal of Cerebral Blood Flow & Metabolism Original Article
Caution urged in trial of stem cells to treat spinal-cord injuryNature Correspondence (05 Mar 2009)
